Morningstar’s analyst picks ResMed and PWR as top ASX long-term plays, with ResMed eyeing sleep market domination.

An AI powered explorer backed by Bill Gates and Jeff Bezos is bringing tech money to mining. What does KoBold's US$537 ...

The Australian stock market has shown resilience, closing nearly flat despite initial predictions of a decline and contrasting with significant drops in major U.S. indices. This unexpected stability, ...

One year into the 10-year forecast, here is the scorecard: from December 1, 2023 to November 30, 2024, the ASX 200 was up 19% ...

Insights into key market performance and economic trends from Dan Kemp, Morningstar’s Global Chief Research and Investment ...

In this first weekly piece of the year, we will look at the "dogs" of the ASX from 2024, see how 2023 Dogs performed and mark ...

However, their asset allocation framework is the foundation of how and where they invest capital. This discipline allows them ...

Analysts are tipping these growing companies as buys. Let's dig deeper into them. The post 4 of the best ASX growth shares to ...

Technology is an exciting sector to find opportunities. The post I think these 2 ASX shares are ideal for growth investors ...

Sonic Healthcare saw its EPS decline at a compound rate of 27% per year, over the last three years. This fall in the EPS is worse than the 15% compound annual share price fall. This suggests that the ...

The Australian sharemarket rose on the first day of trading in 2025, despite futures markets falling 1 per cent before the opening bell on Thursday.

Heading into 2025, value-seeking investors may feel stymied given local shares had a decent run in 2024 and are unlikely to ...